drugset / Trial / NCT00006083
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
RandomizedParallel-groupDouble-blindSupportive care
Summary
RATIONALE: The use of dalteparin may be able to prevent complications caused by the use of a catheter to supply chemotherapy to cancer patients. It is not yet known if dalteparin is effective in reducing these complications. PURPOSE: Randomized phase III trial to determine the effectiveness of dalteparin in preventing catheter-related complications in cancer patients who are receiving chemotherapy through a catheter.
Timeline
- Start
- 2000-04
- Primary completion
- 2000-11
- Completion
- 2000-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalteparin sodium | Other / unclassified | 5000 iu | Subcutaneous |